NCT02915978View on ClinicalTrials.gov

Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

February 10, 2017

Study Completion Date

February 10, 2017

Conditions
Pain
Interventions
DRUG

Fentanyl

Fentanyl delivered via sublingual spray

DRUG

Placebo

Matching placebo delivered via sublingual spray

Trial Locations (2)

85023

Arizona Research Center, Phoenix

92801

Anaheim Clinical Trials, Anaheim

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY